Thompson Davis & Co., Inc. Prime Medicine, Inc. Transaction History
Thompson Davis & Co., Inc.
- $152 Million
- Q3 2025
A detailed history of Thompson Davis & Co., Inc. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 27,573 shares of PRME stock, worth $92,921. This represents 0.1% of its overall portfolio holdings.
Number of Shares
27,573Holding current value
$92,921% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding PRME
# of Institutions
177Shares Held
89.1MCall Options Held
1.32MPut Options Held
931K-
Alphabet Inc. Mountain View, CA16.6MShares$55.8 Million5.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.22MShares$31.1 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.48MShares$18.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$16.6 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $323M